Sugi Predict

Sugi Predict / Compounds / SCHEMBL5800537

SCHEMBL5800537

SCHEMBL5800537

Cc1ccc(-c2ccnc3c(C(=O)c4cccs4)cnn23)cc1NC(=O)c1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDKN1A P38936 1/20 0.57
▸ GSK3A P49840 4/20 0.51
▸ EPHA2 P29317 1/20 0.51
▸ PIM1 P11309 5/20 0.49
▸ AKT1 P31749 2/20 0.49
▸ PIM3 Q86V86 2/20 0.49
▸ LIMK1 P53667 2/20 0.48
▸ MEN1 O00255 2/20 0.48
▸ KMT2A Q03164 2/20 0.48
▸ NPC1 O15118 1/20 0.48
▸ PKM P14618 1/20 0.48
▸ RAB9A P51151 1/20 0.48
▸ SMN1; SMN2 Q16637 1/20 0.48
▸ MAPK13 O15264 3/20 0.46
▸ DAPK3 O43293 1/20 0.46
▸ MAPK9 P45984 1/20 0.46
▸ NEK2 P51955 1/20 0.46
▸ PLK3 Q9H4B4 1/20 0.46
▸ L3MBTL1 Q9Y468 2/20 0.46
▸ LMNA P02545 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5809416 0.90 CDKN1A (0.57) CDKN1AGSK3AEPHA2PIM1AKT1
SCHEMBL5795871 0.89 PIM1 (0.61) CDKN1AGSK3AEPHA2PIM1AKT1
SCHEMBL5811737 0.86 CDKN1A (0.56) CDKN1AGSK3AEPHA2PIM1AKT1
SCHEMBL5807557 0.85 CDKN1A (0.74) CDKN1AGSK3AEPHA2PIM1LIMK1
SCHEMBL5798181 0.85 CDKN1A (0.55) CDKN1AGSK3AEPHA2PIM1AKT1
SCHEMBL5800567 0.85 CDKN1A (0.55) CDKN1AGSK3AEPHA2PIM1AKT1
SCHEMBL5946594 0.85 CDKN1A (0.57) CDKN1AGSK3AEPHA2PIM1AKT1
SCHEMBL5946410 0.84 CDKN1A (0.55) CDKN1AGSK3AEPHA2PIM1AKT1
SCHEMBL5799647 0.83 CDKN1A (0.69) CDKN1AGSK3AEPHA2PIM1LIMK1
SCHEMBL5811225 0.82 CDKN1A (0.59) CDKN1AGSK3AEPHA2PIM1AKT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006033795-A2 SUBSTITUTED PYRAZOLO [1, 5-A] PYRIMIDINES FOR INHIBITING ABNORMAL CELL GROWTH WYETH (US) 2006-03-30 — — WO claimed
WO-2006033796-A1 SUBSTITUTED PYRAZOLO [1,5-a] PYRIMIDINES AND PROCESS FOR MAKING SAME WYETH (US) 2006-03-30 — — WO claimed
US-20060063784-A1 Method of using substituted pyrazolo [1,5-a] pyrimidines WYETH 2006-03-23 — — US claimed
US-20060063785-A1 Substituted pyrazolo[1,5-a] pyrimidines and process for making same WYETH 2006-03-23 — — US claimed
WO-2006033795-A2 SUBSTITUTED PYRAZOLO [1, 5-A] PYRIMIDINES FOR INHIBITING ABNORMAL CELL GROWTH WYETH (US) 2006-03-30 — — WO disclosed
WO-2006033796-A1 SUBSTITUTED PYRAZOLO [1,5-a] PYRIMIDINES AND PROCESS FOR MAKING SAME WYETH (US) 2006-03-30 — — WO disclosed
US-20060063784-A1 Method of using substituted pyrazolo [1,5-a] pyrimidines WYETH 2006-03-23 — — US disclosed
US-20060063785-A1 Substituted pyrazolo[1,5-a] pyrimidines and process for making same WYETH 2006-03-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060063785-A1 Substituted pyrazolo[1,5-a] pyrimidines and process for making same TYMP, DPYD, TYMS CDKN1A 28/4885GSK3A 3144/4885EPHA2 4266/4885
US-20060063784-A1 Method of using substituted pyrazolo [1,5-a] pyrimidines TYMP, DPYD, TYMS CDKN1A 89/4885GSK3A 2702/4885EPHA2 4496/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.